Found 124 clinical trials
Home-based Pulmonary Rehabilitation and Health Coaching in Fibrotic Interstitial Lung Disease
respiratory-related quality of life and physical activity in patients with fibrotic Interstitial Lung Diseases (f-ILD).
- 0 views
- 10 Apr, 2023
- 1 location
PFOX: Pulmonary Fibrosis Ambulatory Oxygen Trial (PFOX)
The fibrotic interstitial lung diseases (fILD) are characterised by lung scarring, distressing breathlessness and poor health-related quality of life. Exertional desaturation (low blood oxygen
- 3 views
- 12 Feb, 2022
- 1 location
Hydroxychloroquin (HCQ) in chILD of Genetic Defect
The purpose of this proposed research is to investigate the efficacy and safety of hydroxychloroquine sulfate (HCQ, Quensyl) for pediatric ILD(chILD) caused by pulmonary surfactant-associated
- 0 views
- 27 Feb, 2022
- 1 location
Cohort for Research and Innovation in Chronic Inflammatory Respiratory Diseases (RINNOPARI)
Chronic inflammatory pulmonary diseases including chronic obstructive pulmonary disease (COPD), interstitial lung diseases (ILD), bronchiectasis, and cystic fibrosis (CF) are characterized by
- 0 views
- 25 Feb, 2022
- 1 location
Hyperpolarized Xenon-129 MR Imaging of the Lung
Over the past 10 years, electronic cigarettes (e-cigarettes, EC) have been commercialized as a "less harmful" alternative to traditional cigarettes.1,2 However, e-cigarettes are believed to cause pulmonary epithelial, endothelial and vascular dysfunction, and to cause murine phenotypes similar to those of human COPD. Recently, "spiked" vape juice has been linked …
- 27 views
- 26 Jan, 2021
- 1 location
Phase 2 Safety and Efficacy Study of PRA023 in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (ATHENA-SSc-ILD)
The purpose of this study is to assess the safety and efficacy of PRA023 in participants with SSc-ILD .
- 0 views
- 29 Jul, 2023
- 54 locations
A Study to Evaluate Long-term Safety of Nintedanib in Children and Adolescents With Interstitial Lung Disease (InPedILD®-ON)
This study is open to children and adolescents with interstitial lung disease (ILD) that causes lung fibrosis. This is a study for people who took part in a previous study (study 1199-0337
- 0 views
- 30 Jul, 2023
- 29 locations
A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
This study is open to adults with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs). People who have a form of PF-ILD other than Idiopathic Pulmonary Fibrosis (IPF) can join the study
- 7 views
- 20 Sep, 2023
- 391 locations
A Study of MK-2225 / ACE-1334 in Participants With Systemic Sclerosis With and Without Interstitial Lung Disease (MK-2225-002)
The purpose of the MK-2225-002 (A1334-02) study is to evaluate the safety and tolerability of MK-2225 (ACE-1334) plus standard of care (SOC) in participants with Systemic Sclerosis (SSc) following multiple doses.
- 2 views
- 22 Aug, 2023
- 3 locations
Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-2)
Study RIN-PF-303 is a multinational study designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from baseline to Week 52.
- 0 views
- 20 Aug, 2023
- 67 locations